TORNWALDT'S DISEASE. ONSET AS SYMPTOMATIC (SECONDARY) GLOSSOPHARYNGEAL NEURALGIA = MALADIE DE TORNWALDT. DEBUT PAR UNE NEVRALGIE GLOSSOPHARYNGEE SYMPTOMATIQUE SECONDAIRESTERN LZ; HALL SW.1972; NEUROLOGY; U.S.A.; DA. 1972; VOL. 22; NO 11; PP. 1182-1185; BIBL. 12REF.Serial Issue

HUMAN PHARMACOLOGY OF PRIBENICILLIN.GROSE WE; BODEY GP; HALL SW et al.1976; CURR. THERAPEUT. RES.; U.S.A.; DA. 1976; VOL. 20; NO 4 PART. 2; PP. 604-609; BIBL. 4 REF.Article

RECALL, RECOGNITION, AND RATE: MEMORY AND THE HEARTJENNINGS JR; HALL SW JR.1980; PSYCHOPHYSIOLOGY; USA; DA. 1980; VOL. 17; NO 1; PP. 37-46; BIBL. 2 P.Article

CLINICAL PHARMACOLOGY OF SYSTEMIC CHEMOTHERAPEUTIC AGENTS IN SKIN NEOPLASMSHALL SW; TI LI LOO.1978; INTERNATION. J. DERMATOL.; USA; DA. 1978; VOL. 17; NO 8; PP. 659-665; BIBL. 24 REF.Article

DISPOSITION AND METABOLISM OF 1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL (FTORAFUR) IN HUMANSBENVENUTO JA; LU K; HALL SW et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 11; PP. 3867-3870; BIBL. 16 REF.Article

BLEOMYCIN CLINICAL PHARMACOLOGY BY RADIOIMMUNOASSAYHALL SW; STRONG JE; BROUGHTON A et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 9; NO 1; PP. 22-25; BIBL. 9 REF.Article

ACTINOMYCIN-D, LEVAMISOLE CHEMOIMMUNOTHERAPY OF REFRACTORY MALIGNANT MELANOMAHALL SW; BENJAMIN RS; LEWINSKI U et al.1979; CANCER; USA; DA. 1979; VOL. 43; NO 4; PP. 1195-1200; BIBL. 13 REF.Article

CLINICAL PHARMACOLOGY OF TETRAHYDROURIDINE.HO DHW; BODEY GP; HALL SW et al.1978; J. CLIN. PHARMACOL.; U.S.A.; DA. 1978; VOL. 18; NO 5-6; PP. 259-265; BIBL. 23 REF.Article

DOXORUBICIN-DNA COMPLEX: A PHASE I CLINICAL TRIAL = COMPLEXE ADRIAMYCINE-ADN: UN ESSAI CLINIQUE PHASE IHALL SW; BENJAMIN RS; BURGESS MA et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 12; PP. 2033-2037; ABS. ENG; BIBL. 13 REF.; GRAPHArticle

KINETICS OF GALLIUM NITRATE, A NEW ANTICANCER AGENTHALL SW; YEUNG K; BENJAMIN RS et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 25; NO 1; PP. 82-87; BIBL. 16 REF.Article

PHASE I STUDY OF MAYTANSINE USING A 3-DAY SCHEDULE.CABANILLAS F; RODRIGUEZ V; HALL SW et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 3; PP. 425-428; BIBL. 3 REF.Article

THE PHARMACOKINETICS OF BLEOMYCIN IN MAN.KRAMER WG; FELDMAN S; BROUGHTON A et al.1978; J. CLIN. PHARMACOL.; USA; DA. 1978; VOL. 18; NO 7; PP. 346-352; BIBL. 15 REF.Article

CLINICAL PHASE I-II STUDY OF CIS-DICHLORO-DIAMMINE-PLATINUM(II) GIVEN BY CONTINUOUS I.V. INFUSIONSALEM P; HALL SW; BENJAMIN RS et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 10; PP. 1553-1555; BIBL. 9 REF.Article

PHASE II STUDY OF 4'-(9-ACRIDINYLAMINO) METHANESULFON-MANISIDIDE(AMSA) IN METASTATIC MELANOMALEGHA SS; HALL SW; POWELL KC et al.1980; CANCER CLIN. TRIALS; USA; DA. 1980; VOL. 3; NO 2; PP. 111-114; BIBL. 6 REF.Article

PHARMACOKINETICS AND DISPOSITION OF 3-DEAZAURIDINE IN HUMANSBENVENUTO JA; HALL SW; FARQUHAR D et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 2; PP. 349-352; BIBL. 5 REF.Article

CLINICAL PHARMACOLOGICAL AND TOXICOLOGICAL STUDIES OF CIS-DIAMMINEDICHLOROPLATINUM (II) BY CONTINOUS INTRAVENOUS INFUSIONTI LI LOO; HALL SW; SALEM P et al.1978; BIOCHIMIE; FRA; DA. 1978; VOL. 60; NO 9; PP. 957-960; BIBL. 13 REF.Conference Paper

PENETRATION OF 3-DEAZAURIDINE INTO HUMAN BRAIN INTRACEREBRAL TUMOR, AND CEREBROSPINAL FLUIDSTEWART DJ; BENVENUTO JA; LEAVENS M et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 10; PP. 4119-4122; BIBL. 27 REF.Article

HEPATIC ARTERIAL INFUSION OF CORYNEBACTERIUM PARVUM AND CHEMOTHERAPYPATT YZ; WALLACE S; HERSH EM et al.1978; SURG. GYNECOL. OBSTETR.; USA; DA. 1978; VOL. 147; NO 8; PP. 897-902; BIBL. 7 REF.Article